Annapurna Das Takeda

Takeda Biopharmaceuticals India Pvt Ltd, a subsidiary of Takeda Pharmaceutical Company Ltd, headquartered in Japan, has recently named Annapurna Das as the General Manager for its operations in India.

With an extensive background spanning over 20 years in the pharmaceutical and biotechnology industry across India and Southeast Asia, Annapurna brings a wealth of experience to her new role. Prior to joining Takeda, she held pivotal leadership positions at renowned multin​​ational healthcare companies such as Miltenyi Biotec, Sanofi, GSK, MSD, Pfizer, and Organon, where she showcased exceptional leadership skills in sales, marketing, corporate strategy, and business development within both pharma and vaccines sectors.

In her new capacity, Annapurna will spearhead Takeda’s operations in India, with a focus on ensuring patient access to the company’s highly innovative medicines and vaccines. She aims to foster valuable collaborations within the domestic healthcare and pharmaceutical market to address the diverse healthcare challenges prevalent in the country.

Expressing her enthusiasm for the appointment, Annapurna stated, “I am truly honored to be entrusted with this responsibility by Takeda. India holds immense significance for us due to its diverse population and healthcare landscape. We are fully committed to serving patients in India by providing them with greater access to our innovative medicines and vaccines, thereby ensuring they receive optimal care.”

Dion Warren, the Area Head of India and Southeast Asia at Takeda, expressed his excitement about Annapurna’s appointment, emphasizing her strategic leadership and dedication to patient-focused solutions. He highlighted Takeda’s commitment to fostering a diverse and inclusive workplace, aligning with Annapurna’s values and reinforcing their dedication to creating long-term value for patients and society.

Takeda India specializes in various therapeutic areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, and oncology. Annapurna’s appointment signifies Takeda’s ongoing commitment to advancing healthcare solutions and partnerships to broaden sustainable and equitable access to medicines and vaccines in India.

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

Related News